Catalyst-free synthesis of imidazo[5,1-b]quinazolines and their antimicrobial activity

[1]  Divyang M. Patel,et al.  Catalyst-Free, Room-Temperature Accessible Regioselective Synthesis of Spiroquinolines and Their Antioxidant Study , 2022, ACS omega.

[2]  Manish P. Patel,et al.  1,2,4‐Triazole and benzimidazole fused dihydropyrimidine derivatives: Design, green synthesis, antibacterial, antitubercular, and antimalarial activities , 2022, Archiv der Pharmazie.

[3]  Y. Ammar,et al.  Development of new spiro[1,3]dithiine-4,11'-indeno[1,2-b]quinoxaline derivatives as S. aureus Sortase A inhibitors and radiosterilization with molecular modeling simulation. , 2022, Bioorganic chemistry.

[4]  H. Patel,et al.  Versatile Synthetic Platform for 1,2,3-Triazole Chemistry , 2022, ACS omega.

[5]  R. Chandra,et al.  Click Reaction Inspired Synthesis, Antimicrobial Evaluation and In Silico Docking of some Pyrrole-Chalcone Linked 1,2,3-Triazole Hybrids , 2022, Journal of Molecular Structure.

[6]  Celestine N. Chi,et al.  Water mediated TBAB catalyzed synthesis of spiro-indoline-pyrano[3,2-c]quinolines as a-Amylase Inhibitor and In Silico Studies , 2022, Journal of Molecular Structure.

[7]  Yanlong Gu,et al.  Synthesis of N-(4-chlorophenyl) substituted pyrano[2,3-c]pyrazoles enabling PKBβ/AKT2 inhibitory and in vitro anti-glioma activity , 2022, Annals of medicine.

[8]  R. Gardas,et al.  Crystal structure, antibacterial and antifungal evaluation of 5-bromothiophene based 3,4-dihydropyrimidin-2-(1H)-(thi)ones , 2022, Phosphorus, Sulfur, and Silicon and the Related Elements.

[9]  Deepak R. Mishra,et al.  One-pot multicomponent synthesis of 4-((2H-chromen-3-yl)/(2-phenyl-2H-chromen-3-yl)methylene)-3-methylisoxazol-5(4H)-ones and evaluation of their antibacterial activity , 2022, Tetrahedron.

[10]  Manish P. Patel,et al.  Anomaly of Pyrano[2,3‐c]pyrazole Synthesis towards Pyrazolyl‐aryl‐methyl‐malononitrile Derivatives and Their Antimicrobial Activity , 2022, ChemistrySelect.

[11]  E. Fayed,et al.  Evaluation of Quinoxaline Derivatives as Potential Ergosterol Biosynthesis Inhibitors: Design, Synthesis, ADMET, Molecular Docking Studies, and Antifungal Activities , 2022, Journal of Molecular Structure.

[12]  Marwa Mohsen,et al.  Novel cyclohepta[b]thiophene derivative incorporating pyrimidine, pyridine, and chromene moiety as potential antimicrobial agents targeting DNA gyrase , 2022, Journal of Molecular Structure.

[13]  Y. Ammar,et al.  One-Pot Synthesis and Molecular Modeling Studies of New Bioactive Spiro-Oxindoles Based on Uracil Derivatives as SARS-CoV-2 Inhibitors Targeting RNA Polymerase and Spike Glycoprotein , 2022, Pharmaceuticals.

[14]  Ahmed Atef,et al.  In vitro antimicrobial evaluation and in silico studies of coumarin derivatives tagged with pyrano-pyridine and pyrano-pyrimidine moieties as DNA gyrase inhibitors , 2021, Molecular diversity.

[15]  V. Khedkar,et al.  Quinazoline clubbed thiazole and 1,3,4-oxadiazole heterocycles: synthesis, characterization, antibacterial evaluation, and molecular docking studies , 2021 .

[16]  S. Kovalenko,et al.  Synthesis, antimicrobial, and mitotic toxicity evaluation of new 6‐substituted 2‐(benzo[4,5]imidazo[1,2‐ c ]quinazolin‐5( 6 H )‐yl)acetic acids , 2020 .

[17]  R. Gardas,et al.  One-Pot Assembly for Synthesis of 1,4-Dihydropyridine Scaffold and Their Biological Applications , 2019, Polycyclic Aromatic Compounds.

[18]  Y. Ammar,et al.  Design, synthesis, molecular docking and biological activity evaluation of some novel indole derivatives as potent anticancer active agents and apoptosis inducers. , 2019, Bioorganic chemistry.

[19]  M. Yadav,et al.  Evaluation of Anticonvulsant Activity and Toxicity Screening of Semicarbazones Derived from Quinazolinone Scaffold , 2019, Current Bioactive Compounds.

[20]  R. Rappuoli,et al.  Technologies to address antimicrobial resistance , 2018, Proceedings of the National Academy of Sciences.

[21]  Om P. S. Patel,et al.  Design and Synthesis of Imidazo/Benzimidazo[1,2-c]quinazoline Derivatives and Evaluation of Their Antimicrobial Activity , 2018, ACS omega.

[22]  A. Abdel-Razek,et al.  Erratum to: One pot synthesis, antimicrobial and antioxidant activities of fused uracils: pyrimidodiazepines, lumazines, triazolouracil and xanthines , 2017, Chemistry Central Journal.

[23]  Olivier Michielin,et al.  SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules , 2017, Scientific Reports.

[24]  A. Mándi,et al.  Synthesis and configurational assignment of 1,2-dihydroimidazo[5,1-b]quinazoline-3,9-diones: novel NMDA receptor antagonists , 2012 .

[25]  Y. Lou,et al.  Anti-tumor effects of B-2, a novel 2,3-disubstituted 8-arylamino-3H-imidazo[4,5-g]quinazoline derivative, on the human lung adenocarcinoma A549 cell line in vitro and in vivo. , 2011, Chemico-biological interactions.

[26]  Y. Haishima,et al.  Determination of a new type of phosphodiesterase-5 inhibitor, thioquinapiperifil, in a dietary supplement promoted for sexual enhancement. , 2008, Chemical & pharmaceutical bulletin.

[27]  K. Abouzid,et al.  Ligand design and synthesis of new imidazo[5,1-b]quinazoline derivatives as alpha1-adrenoceptor agonists and antagonists. , 2006, Bioorganic & medicinal chemistry.

[28]  C. Masaguer,et al.  Synthesis and Biological Evaluation of New Quinazoline and Cinnoline Derivatives as Potential Atypical Antipsychotics , 2006, Chemistry & biodiversity.

[29]  G. Keating,et al.  Anagrelide: a review of its use in the management of essential thrombocythaemia. , 2006, Drugs.

[30]  V. Tumiatti,et al.  Design, synthesis, and biological evaluation of prazosin-related derivatives as multipotent compounds. , 2005, Journal of medicinal chemistry.

[31]  P. Tsvetkov,et al.  DNA gyrase interaction with coumarin-based inhibitors: the role of the hydroxybenzoate isopentenyl moiety and the 5'-methyl group of the noviose. , 2002, Biochemistry.

[32]  P. Barabas,et al.  Quinazolone-alkyl-carboxylic acid derivatives inhibit transmembrane Ca(2+) ion flux to (+)-(S)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid. , 2001, Molecular Pharmacology.

[33]  M. Malamas,et al.  Quinazolineacetic acids and related analogues as aldose reductase inhibitors. , 1991, Journal of medicinal chemistry.

[34]  M. Venuti,et al.  Inhibitors of cyclic AMP phosphodiesterase. 1. Analogues of cilostamide and anagrelide. , 1987, Journal of medicinal chemistry.

[35]  G. Cristalli,et al.  Synthesis of 2,3,5,6‐tetrahydroimidazo[1,2‐c]quinazoline derivatives as potential narcotic antagonists , 1980 .

[36]  K. Rieckmann,et al.  Malaria immunity induced by infection with cultured parasites of Plasmodium falciparum. , 1978, The Journal of parasitology.

[37]  B. Loev,et al.  Amidines. 2. A new class of antihypertensive agents. 1,2,3,5-Tetrahydroimidazo(2,1-b)quinazolines. , 1972, Journal of medicinal chemistry.